Root Financial Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.07K Buy
+64
New +$2.45K ﹤0.01% 2625

Other funds holding CLDX

Root Financial Partners's CLDX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Celldex Therapeutics (CLDX) in Q3 2026: 64 shares worth $2.07K. The stake represents ﹤0.01% of the portfolio and ranks #2625 among its holdings.

249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.

  • Root Financial Partners held 64 shares of Celldex Therapeutics worth $2.07K as of Q3 2026.
  • Celldex Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Celldex Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2625 holding.
  • 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.